OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies ...
GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...
AdAlta (ASX:1AD) is bringing cellular immunotherapy products from Asian to western markets to drive value creation.
AZoLifeSciences on MSN14h
Zika Virus Tricks Mosquitoes by Making Infected Humans Smell More AppealingRecent research reveals Zika virus modifies host odors, making infected individuals more attractive to mosquitoes, impacting ...
Financial GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs 05.02.2025 / 15:06 CET/CEST The issuer is solely responsible for the content of this ...
Viralgen and the CTNNB1 Foundation have come together to manufacture an investigational gene therapy designed to treat CTNNB1 ...
Pulse Nigeria on MSN18h
Anambra records 156 dog bites in 2 years, seeks more funding for NTD researchThe Anambra State Government, in partnership with Carter Centre, said it recorded and treated 156 dog bite cases between 2023 ...
"The incessant movement of unvaccinated homeless, stray dogs in our streets remains a big challenge of public health." ...
Nigerian Tribune on MSN17h
Rabies alert: Anambra treats 156 dog bite victims – OfficialThe Anambra State Government, in partnership with Carter Centre, said it recorded and treated 156 dog bite cases between 2023 and 2024. The Commissioner ...
Kingdom Come: Deliverance 2 is one of 2025's biggest early hits, selling more than 1 million copies in its first day and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback